Nebraska cannabis growers face up to 2-year wait to sell products

Nebraska's four licensed medical cannabis cultivators want regulators to revise testing rules and change the fee structure.
Published: October 21, 2026

Nebraska’s licensed medical cannabis cultivators could wait up to two more years before they’re allowed to test and sell their products as the state works to finalize rules for testing, manufacturing and distribution, according to Nebraska Public Media.

The delay shouldn’t come as a surprise to growers, Medical Cannabis Commission member Lorelle Mueting said during a meeting Monday, according to the news outlet.

How are regulatory delays affecting Nebraska cannabis cultivators?

Testing is the gateway to retail sales in regulated cannabis markets. Cultivators need clear rules on potency, contaminants and lab procedures before products can reach patients.

Nebraska has yet to license testing laboratories, manufacturers or dispensaries, leaving growers without a clear path to market.

new framework ctas (2)

Mueting said the commission had warned cultivators that testing and other parts of the supply chain might not be ready by their first harvest. She said growers had assured regulators they could store their crops while waiting for the program to develop.

Of the state’s four licensed cultivators, only Mahamota Cultivation Co. has plants growing, with its first harvest expected within seven weeks of the commission’s Oct. 19 meeting, according to company representative Garrett Elting.

Elting warned that cannabis can lose potency after three to six months in storage, even under temperature-controlled conditions.

The longer growers must store their crops, the greater the risk of product degradation and rising operating costs without revenue.

What changes are Nebraska cannabis cultivators seeking?

The state’s four licensed cultivators are asking regulators to revise several parts of the current framework, including testing requirements and licensing fees.

In an Oct. 15 letter to the commission, the growers sought clearer rules for laboratory testing and relief from proposed annual fees totaling $36,500, including a $23,500 license renewal fee and a $13,000 inventory tracking fee.

They want the fees deferred, reduced or phased in until businesses have a viable path to revenue.

Subscribe to the MJBiz Factbook  

Exclusive industry data and analysis to help you make informed business decisions and avoid costly missteps. All the facts, none of the hype. 

What you will get: 

  • Monthly and quarterly updates, with new data & insights
  • Financial forecasts + capital investment trends
  • State-by-state guide to regulations, taxes & market opportunities
  • Annual survey of cannabis businesses
  • Consumer insights
  • And more!

Nebraska voters approved medical cannabis in November 2024, but nearly two years later, patients still can’t legally buy medicine in the state.

The commission anticipates revised regulations taking effect in early 2027, with manufacturer licensing to follow. But there is still no firm timeline for when cultivators can begin selling their products.

MJBizCon Logo